Trials / Unknown
UnknownNCT06033040
Medical Imaging in Bladder Tumors by MRI
Clinical Study on the Diagnostic and Predictive Value of MRI Multifunctional Imaging in Bladder Tumors
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 178 (estimated)
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
This study prospectively included 178 patients with bladder neoplastic lesions who planned to undergo surgery (with or without preoperative neoadjuvant chemotherapy). Inclusion criteria: Patients with pathologically confirmed bladder cancer after radical or partial cystectomy or TURBT (\< 2 weeks between surgical resection and imaging). Exclusion criteria: 1) Prior history of chemotherapy and/or radiotherapy; 2) No surgical resection; 3) The interval between surgical resection and imaging examination is \> 2 weeks; 4) Obvious artifacts; 5)MRI scan contraindications. All subjects underwent pelvic MRI. Data was collected using a Siemens VIDA 3TMR scanner (Siemens Healthcare, Erlangen, Germany). All subjects underwent standardized scanning protocols. The obtained images are post-processed and the experimental results are analyzed statistically.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | MRI | Functional sequence imaging (MDME, IVIM) sequences were added to the routine MRI scan of patients with bladder tumor |
Timeline
- Start date
- 2023-08-15
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2023-09-13
- Last updated
- 2023-09-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06033040. Inclusion in this directory is not an endorsement.